Crumly & Associates Inc. Merck & Co., Inc. Transaction History

Crumly & Associates Inc.

  • $317 Million
  • Q2 2024

A detailed history of Crumly & Associates Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crumly & Associates Inc. holds 7,626 shares of MRK stock, worth $837,106. This represents 0.3% of its overall portfolio holdings.

Number of Shares
7,626
Previous 7,691 0.85%
Holding current value
$837,106
Previous $1.01 Million 6.9%
% of portfolio
0.3%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
SELL
$123.8 - $132.96 $8,047 - $8,642
-65 Reduced 0.85%
7,626 $944,000
Q1 2024

May 01, 2024
BUY
$113.24 - $131.95 $6,228 - $7,257
55 Added 0.72%
7,691 $1.01 Million
Q4 2023

Jan 29, 2024
BUY
$100.18 - $109.02 $1,502 - $1,635
15 Added 0.2%
7,636 $832,000
Q4 2023

Jan 29, 2024
BUY
$100.18 - $109.02 $94,970 - $103,350
948 Added 14.21%
7,621 $830,000
Q3 2023

Nov 02, 2023
BUY
$102.95 - $114.33 $40,047 - $44,474
389 Added 6.19%
6,673 $686,000
Q2 2023

Jul 21, 2023
SELL
$108.61 - $118.38 $120,122 - $130,928
-1,106 Reduced 14.97%
6,284 $725,000
Q1 2023

Apr 24, 2023
BUY
$102.94 - $114.86 $51,058 - $56,970
496 Added 7.19%
7,390 $786,000
Q4 2022

Mar 03, 2023
SELL
$87.44 - $112.11 $14,165 - $18,161
-162 Reduced 2.3%
6,894 $764,000
Q3 2022

Oct 25, 2022
SELL
$84.53 - $94.96 $8,706 - $9,780
-103 Reduced 1.44%
7,056 $607,000
Q2 2022

Aug 01, 2022
SELL
$83.49 - $94.64 $62,367 - $70,696
-747 Reduced 9.45%
7,159 $653,000
Q1 2022

May 02, 2022
BUY
$73.51 - $82.4 $47,855 - $53,642
651 Added 8.97%
7,906 $648,000
Q4 2021

Feb 04, 2022
SELL
$72.28 - $90.54 $534,799 - $669,905
-7,399 Reduced 50.49%
7,255 $573,000
Q3 2021

Oct 20, 2021
BUY
$71.68 - $78.83 $243,855 - $268,179
3,402 Added 30.23%
14,654 $1.1 Million
Q2 2021

Aug 09, 2021
BUY
$70.31 - $77.77 $329,472 - $364,430
4,686 Added 71.37%
11,252 $875,000
Q1 2021

Apr 27, 2021
BUY
$68.86 - $81.11 $45,378 - $53,451
659 Added 11.16%
6,566 $506,000
Q4 2020

Jan 25, 2021
SELL
$71.77 - $79.65 $90,645 - $100,597
-1,263 Reduced 17.62%
5,907 $478,000
Q3 2020

Oct 21, 2020
BUY
$73.18 - $82.95 $39,736 - $45,041
543 Added 8.19%
7,170 $567,000
Q2 2020

Jul 07, 2020
BUY
$70.42 - $80.13 $199,640 - $227,168
2,835 Added 74.76%
6,627 $512,000
Q1 2020

Apr 21, 2020
BUY
$63.36 - $87.82 $240,261 - $333,013
3,792 New
3,792 $292,000

Others Institutions Holding MRK

# of Institutions
3,828
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Crumly & Associates Inc. Portfolio

Follow Crumly & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crumly & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crumly & Associates Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email